Average Co-Inventor Count = 2.95
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Sequencing Solutions, Inc. (11 from 277 patents)
2. Avails Medical, Inc. (4 from 29 patents)
3. Samtec Incorporated (3 from 255 patents)
4. Roche Molecular Systems, Inc. (2 from 622 patents)
5. Roche Diagnostics Gmbh (480 patents)
6. F. Hoffmann-la Roche Ag (168 patents)
7. Genia Technologies, Inc. (62 patents)
8. F. Hoffmann-la Roche Sa (0 patent)
20 patents:
1. 12365941 - Non-destructive bilayer monitoring using measurement of bilayer response to electrical stimulus
2. 12173367 - Electrical enhancement of bilayer formation
3. 12139743 - Method for inline bilayer capacitance monitoring
4. 12129509 - Apparatus, systems, and methods for determining the susceptibility of infectious agents to anti-infectives
5. 12007350 - Devices, systems, and methods for measuring a solution characteristic of a sample comprising microorganisms
6. 11891661 - Non-destructive bilayer monitoring using measurement of bilayer response to electrical stimulus
7. 11814676 - Electrical enhancement of bilayer formation
8. 11725229 - Method for inline bilayer capacitance monitoring
9. 11536682 - Devices, systems, and methods for measuring a solution characteristic of a sample comprising microorganisms
10. 11530443 - Non-destructive bilayer monitoring using measurement of bilayer response to electrical stimulus
11. 11041198 - Electrical enhancement of bilayer formation
12. D901036 - Cuvette
13. 10683543 - Non-destructive bilayer monitoring using measurement of bilayer response to electrical stimulus
14. 10648016 - Method for inline bilayer capacitance monitoring
15. 10465240 - Electrical enhancement of bilayer formation